Phase I study of 506U78 administered on a consecutive 5-day schedule in children and adults with refractory hematologic malignancies.
暂无分享，去创建一个
J. Kurtzberg | B. Mitchell | M. Keating | V. Gandhi | T. Ernst | G. Elion | D. Kisor | C. Stephens | T. Krenitsky | J. Lager | J. Hodge | J. Levin | Joanne Kurtzberg | Varsha Gandhi | David F. Kisor | Joanne J. Lager | Gertrude B. Elion | Beverly S. Mitchell